Please login to the form below

Not currently logged in

Tizona Therapeutics

This page shows the latest Tizona Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Gilead agrees $21bn buyout of Immunomedics

Gilead agrees $21bn buyout of Immunomedics

Gilead has been bolstering its oncology portfolio over the course of this year, with prior deals including a play for Tizona Therapeutics and its lead antibody candidate, as well as its

Latest news

  • Gilead makes a play for novel cancer drug with Tizona deal Gilead makes a play for novel cancer drug with Tizona deal

    Pharma company continues oncology biotech spending spree. Gilead has made a play for another small oncology specialist, Tizona Therapeutics, as it continues its foray into the immunotherapy research and development space. ... Tizona is also set to

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Jet Off with Maloff Protect

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...